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Purpose. Diagnosis of WNV (WNV) relies upon serologic testing which may take several days after the onset of clinical symptoms
to turn positive. Anecdotal reports suggest the presence of plasma cells or plasmacytoid lymphocytes in the cerebrospinal ﬂuid
(CSF) may be an early indicator of WNV infection. Methods. The CSFs of 89 patients (12 with WNV, 12 with other viral illness
{OVI}, and 65 with nonviral illness{NVI}) were compared for the presence of either plasma cells or plasmacytoid lymphocytes.
Results. Plasma cells were rarely seen in any of the patients. Plasmacytoid lymphocytes were more commonly seen in WNV (58%)
and OVI (50%) than NVI (11%). The diﬀerences were signiﬁcant for WNV versus NVI, but not WNV versus OVI (P<0.001 and
P = 0.58, resp.). Conclusions. A CSF pleocytosis with plasma cells or plasmacytoid lymphocytes was neither sensitive nor speciﬁc
for the diagnosis of WNV infection.
1.Introduction
West Nile virus, a mosquito-borne ﬂavivirus, ﬁrst appeared
in North America in the New York City metropolitan area
in 1999. Since that time, the ArboNET surveillance system
hasdocumentedthevirus’dramaticspreadacrosstheUnited
States with 30,662 cases of WNV disease reported from 47
statesthrough2010[1,2].Over11000caseswereclassiﬁedas
West Nile neuroinvasive disease (WNND), and over 1000 of
these cases died with their infection. WNV has now become
the leading cause of arboviral encephalitis in the United
States with likely ongoing seasonal epidemic transmission
[2].
Symptoms of WNV infection are nonspeciﬁc, and deﬁni-
tive diagnosis rests on ﬁnding WNV RNA in CSF or blood,
or more commonly, serologic evidence of recent infection
as evidenced by the presence of IgM-speciﬁc antibodies to
WNV antigens in CSF or blood. However, this test may not
turn positive until 8–21 days after the ﬁrst appearance of
symptoms [3]. Finding earlier indicators for WNV would
facilitate making a more rapid diagnosis. In the setting of
meningitis or encephalitis, previous anecdotal reports have
suggested the presence of plasma cells or plasmacytoid lym-
phocytes in CSF may be an early indicator of WNV infection
[4–7]. Plasma cells originate in the bone marrow as B cells
andafterantigenicstimulationundergodiﬀerentiationinthe
lymph node from lymphocyte to plasmacytoid lymphocyte
to the plasma cell capable of producing large amounts of
antibodies. WNV is known to induce a brisk antibody
response that is largely responsible for clearing of the virus
[8, 9]. It is not clear that the cells previously observed in the
aforementioned studies are truly plasma cells. In one study
of transplant patients with WNV infection, ﬁve patients
had cytology performed on the CSF that showed atypical
lymphocytes and plasma cells. However, ﬂow cytometry was
performed on 3 of these patients which showed the cells were
predominantly mature T cells with only negligible B cells
present [7].2 Journal of Biomedicine and Biotechnology
Table 1: CSF cell count ﬁndings in WNV-infected patients versus patients with other viral illness (OVI) or non-viral illness (NVI).
Variable Display
meaning WNV infection Other viral
illness Non-viral illness
P values for tests
Overall
WNV
versus
OVI
WNV
versus
NVI
Total N n = 12 n = 12 n = 6 5 ———
Gender M 50.0 50.0 50.8 0.98 — —
Age Mean (SD) 51.2 (17.5) 37.1 (16.1) 35.5 (27.1) 0.13 — —
RBC Mean (SD) 42.3 (53.3) 642.3 (2095.3) 28858.4 (179338.1) 0.74 0.99 0.55
WBC Mean (SD) 236.7 (265.1) 325.0 (446.0) 174.9 (561.6) 0.64 0.68 0.71
% Lymphocytes Mean (SD) 41.6 (27.1) 53.9 (28.9) 58.2 (30.7) 0.22 0.32 0.08
% Monocytes Mean (SD) 12.0 (5.8) 25.8 (20.1) 18.8 (19.3) 0.19 0.07 0.24
% Neutrophils Mean (SD) 44.4 (28.9) 18. 7(29.8) 23.1 (30.8) 0.07 0.04 0.03
% PC lymphocytes Mean (SD) 1.8 (2.1) 1.1 (1.4) 0.1 (0.4) <.0001 0.06 <.0001
% Plasma Cells Mean (SD) 0.2 (0.6) 0.3 (0.7) 0.1 (0.4) 0.30 0.38 0.69
PC lymphocytes present N (%) 7/12 (58.3) 6/12 (50.0) 7/65 (10.8) <.0001 0.58 <.0001
Plasma Cells present N (%) 1/12 (8.3) 3/12 (25.0) 5/65 (7.7) 0.18 0.17 0.94
We sought to determine the utility of the anecdotal ﬁnd-
ing of plasma cell CSF pleocytosis by calculating sensitivity
and speciﬁcity among a larger group of patients undergoing
lumbar puncture for a variety of indications.
2.SubjectsandMethods
FromJune2007toAugust2008,slidessubmittedtoourlabo-
ratory forCSF cell counts were saved forfuture investigation.
Patients were excluded if they were under the age of 1 month
or had a known immunosuppressive condition. Eighty-nine
slides had enough cells present to be able to do a 100-
cell diﬀerential count. Subject’s records were reviewed for
the ﬁnal diagnosis pertaining to the lumbar puncture, CSF
white blood cell (WBC) count, red blood cell (RBC) count,
WBCdiﬀerential,andWNVtestresults(ifdone).Slideswere
then reviewed with a 100-cell diﬀerential count speciﬁcally
looking for the presence of plasma cells or plasmacytoid
lymphocytes based on standard morphologic criteria [10].
Only one person reviewed all the slides and was blinded to
the patient’s diagnosis.
Patients with WNV were compared for the presences
of plasma cells or plasmacytoid lymphocytes in the CSF
to patients with other viral illness and those without
any presumed CNS infection. Diﬀerences between groups
were tested using generalized linear methods (for binomial
variables) or ANOVA methods (for continuous variables),
with contrasts used to test diﬀerences between groups within
the overall three-group diﬀerence. Diﬀerences were also
examined using nonparametric methods, with equivalent
results. Tests were performed using SAS V. 9.2 software.
3. Results
Twelve patients tested positive for WNV by IgM capture
ELISA. Five of the WNV patients had meningoencephalitis,
7 had just meningitis. Twelve other patients were thought to
have a viral illness other than WNV. Eleven of these patients
had negative testing for the presence of WNV-speciﬁc IgM
antibodies in serum, and 6 had speciﬁc other viral infections
diagnosed (3 with enterovirus, 2 with herpes simplex type
II, and one with Epstein-Barr virus). Details of the CSF
ﬁndings for WNV patients versus patients with other viral
illnesses versus patients with no presumed infection are
summarized in Table 1. WNV patients were older and more
likely to have neutrophils in their CSF. When compared to
patients without presumed infection, they were more likely
to have plasmacytoid lymphocytes in their CSF. However,
the sensitivity of this ﬁnding was relatively low (58%),
and the overall percentage of plasmacytoid lymphocytes
was relatively low (mean of 1.8%). However, when patients
with WNV were compared only to patients with other
viral infection, ﬁnding plasmacytoid lymphocytes was not
speciﬁc for WNV. Six out of twelve patients with other
viral syndromes had plasmacytoid lymphocytes present,
suggesting a speciﬁcity of only 50%. The presence of plasma
cells was rare in WNV patients (only 1/12) and was actually
more common in the other viral illnesses (3/12). Combining
the presence of plasma cells and plasmacytoid lymphocytes
did not enhance sensitivity or speciﬁcity. If we compared
the WNV encephalitis patients with the WNV meningitis
patients, plasmacytoid lymphocytes were seen rarely in the
encephalitis cases (1/5) whereas they were frequently seen in
the meningitis cases (6/7).
4. Discussion
Our study did not conﬁrm earlier anecdotal ﬁndings that
plasma cells or plasmacytoid lymphocytes may be an early
marker for WNV infection. The overall sensitivity of this
ﬁndingwasonly58%.Thesensitivityincreasedto86%ifone
excluded the WNV encephalitis cases and only considered
the WNV meningitis cases. However, this may be a spurious
ﬁnding due to the low numbers of subjects in either group.Journal of Biomedicine and Biotechnology 3
All of the encephalitis cases also had meningitis with nearly
equivalent numbers of total WBCs in the CSF, so a distinc-
tion between these clinical entities which lie on a spectrum
ofillnesswouldseemunlikely.Mostimportantly,thisﬁnding
was seen in several of our patients with other forms of viral
meningitis, thus suggesting a signiﬁcant lack of speciﬁcity.
It is likely that the presence of plasma cells or plas-
macytoid lymphocytes is simply a nonspeciﬁc marker of
central nervous system infection. Of note is that, in our
prior reported case series of 4 patients, all had underlying
conditions causing variable degrees of immunosuppres-
sion: myelodysplasia, myeloproliferative disorder, Graves’
disease, and renal/pancreas transplantation. This suggests
that immunosuppression may have played a role in the
development of the plasma cell pleocytosis.
It should be noted that plasma cells and plasmacytoid
lymphocytes have been noted in the CSF of several other
infections including HIV [11], tuberculous meningitis [12],
neuroborreliosis [13], neurocysticercosis [14], secondary
syphilis [15], herpes zoster meningoencephalitis [16], and
African sleeping sickness [17]. Furthermore, the morpho-
logic characterization of what constitutes a plasma cell
or plasmacytoid lymphocyte is somewhat subjective and,
therefore, technician dependent. One might expect further
diminishing of speciﬁcity in real-life conditions where
diﬀerent laboratory technicians would be interpreting these
cell diﬀerentials variably.
5. Conclusions
The ﬁnding of plasma cells or plasmacytoid lymphocytes in
the CSF was neither sensitive nor speciﬁc for the diagnosis of
West Nile virus infection. Other modalities or improvements
in current laboratory testing will need to be sought if we
hope to improve on the timeliness of diagnosing acute WNV
infection.
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